Development and validation of a stability indicating analytical method for the related substances of Bosentan drug substance by HPLC

@article{Khan2012DevelopmentAV,
  title={Development and validation of a stability indicating analytical method for the related substances of Bosentan drug substance by HPLC},
  author={M. A. Khan and Sukumar Sinha and Mangesh Todkar and Vikas Parashar and K. C. Narayana Swamy and Navi Mumbai},
  journal={American Journal of Scientific and Industrial Research},
  year={2012},
  volume={3},
  pages={69-80}
}
An accurate & sensitive stability indicating analytical method has been developed for the control of impurities in Bosentan API. Four impurities (impurity A, B, C & D) were isolated from the API and were characterized by spectroscopic studies. An HPLC equipped with quaternary gradient pumps, variable wavelength UV detector attached with data recorder and integrator software was used. A Zorbax SB-C8 (250 x 4.6mm, 5µ) column at 25°C was used with a flow rate of 1.0 ml/min and the compounds were… 

Figures and Tables from this paper

Stability Indicating Method Development and Validation of Bosentan in Bulk Drug and Formulation by Rp-Hplc Method
A simple and selective stability indicating RP-HPLC Method is developed and validated for the quantification of Bosentan in bulk and tablet dosage form. Quantification was achieved by using the
Determination of Bosentan in Pharmaceutical Dosage Forms by High Performance Liquid Chromatography
A simple and sensitive high performance liquid chromatographic method is developed for the estimation of bosentan in pharmaceutical dosage forms. Chromatographic separation of the drug was achieved
Pharmacological and therapeutic properties of new derivatives of renin inhibitors and endothelin receptor antagonists, and the methods of their determination
TLDR
This review presents new information concerning analytical methods used in order to determine new substances of hypotensive activity belonging to two pharmacological groups, i.e., renin inhibitors and endothelin receptor antagonists.

References

SHOWING 1-6 OF 6 REFERENCES
Evolving bioanalytical methods for the cardiovascular drug bosentan
SummaryThe history of the development of analytical methods for the determination of the cardiovascular agent bosentan, and its three major metabolites in biological fluids is described. Before the
Development, Estimation And Validation Of Oseltamivir In Bulk And In Its Pharmaceutical Formulation By UV-VIS Spectroscopic Method
TLDR
The objective was to develop a simple, sensitive, accurate and precise method for determination of Prasugrel by uv-visible spectrophotometric method in the pure form and its tablet formulation as per ICH guide lines.
“ petrophotometric determination of bosentan and its application in pharmaceutical analysis . ”
  • Int . J . Comprehen . Pharm .
  • 2011
HPLC method for the analysis of Bosentan substances and use of these substances as reference standards and markers
  • WO 2010/061210
  • 2009